These findings highlight the recently identified role of C5a-C5aR in metabolic disorders such as obesity, while supporting an anti-inflammatory role for C5aR antagonists in animal models of inflammatory diseases [41, 42]. This evidence concerns the gene C5 and obesity due to melanocortin 4 receptor deficiency.